Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Brooke R Tader

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5214-2068; OpenAlex author ID A5027355710. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 2 papers

Papers 4

  1. Nuclear VAV1 increases GLI1-dependent transcription in pancreatic cancer cells. Co-author DOI 10.1016/j.jbc.2025.110988↗
  2. A Novel Emerin/Nesprin-3 Interaction Mediates Nuclear Size Changes Induced by Oncogenic KRAS in Pancreatic Cancer Cells. Co-author DOI 10.1080/10985549.2026.2670710↗
  3. Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancer. Co-author DOI 10.1172/jci.insight.187799↗
  4. Nuclear Dynamics and Chromatin Structure: Implications for Pancreatic Cancer. First author DOI 10.3390/cells10102624↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Martín E. Fernández-Zapico · 4 shared papers, 2021–2026 · strength 0.91
  2. Kayla C. LaRue-Nolan · 3 shared papers, 2025–2026 · strength 0.75
  3. Luis F. Flores · 3 shared papers, 2021–2026 · strength 0.62
  4. Renzo Emanuel Vera · 2 shared papers, 2025–2026 · strength 0.46
  5. Ezequiel J. Tolosa · 2 shared papers, 2021–2025 · strength 0.35
  6. Daniel D. Billadeau · 1 shared paper, 2026 · strength 0.29
  7. Aleksey V. Matveyenko · 1 shared paper, 2025 · strength 0.19
  8. Catherine E. Hagen · 1 shared paper, 2025 · strength 0.19
  9. Rondell Patrell Graham · 1 shared paper, 2025 · strength 0.19
  10. David R Pease · 1 shared paper, 2025 · strength 0.19
  11. Ryan Michael Carr · 1 shared paper, 2025 · strength 0.19
  12. Christopher L. Pin · 1 shared paper, 2025 · strength 0.19
  13. David W. Dawson · 1 shared paper, 2025 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.